USPTO serial 90570724
IBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 1, 2022
- Examiner
- SINGH, TEJBIR
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bryan, TX
New York, NY
New York, NY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel J. Chalker
Daniel J. Chalker Chalker Flores, LLP14841 Dallas Pkwy.Suite 575Dallas, TX 75254Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical plant based drug development services; Pharmaceutical plant based products development; Pharmaceutical research and development in plants; Pharmaceutical plant based research services; Conducting early evaluations in the field of new plant based pharmaceuticals; Development of plant based pharmaceutical preparations and medicines; Laboratory plant based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials in plants; Providing medical and scientific research information in the fields of pharmaceuticals and genetics made in plants; Research and development in the pharmaceutical and biotechnology fields made in plants; Research and development of plant based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of plant based pharmaceuticals; Research on the subject of plant based pharmaceuticals; Technical research in the field of plant based pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made in plants | ACTIVE | Aug 10, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jun 29, 2024 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Jun 28, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Apr 30, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Mar 22, 2024 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Mar 18, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 1, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Feb 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 27, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2021 | NWAP | NEW APPLICATION ENTERED | — |